GH Research PLC
GHRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $11 | $9 | $8 | $8 |
| G&A Expenses | $0 | $6 | $5 | $5 |
| SG&A Expenses | $6 | $6 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $16 | $15 | $13 | $13 |
| Operating Income | -$17 | -$15 | -$13 | -$13 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3 | $5 | $2 | $4 |
| Pre-Tax Income | -$14 | -$9 | -$11 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$9 | -$11 | -$9 |
| % Margin | – | – | – | – |
| EPS | -0.23 | -0.15 | -0.19 | -0.17 |
| % Growth | -53.3% | 21.1% | -11.8% | – |
| EPS Diluted | -0.23 | -0.15 | -0.19 | -0.17 |
| Weighted Avg Shares Out | 62 | 62 | 58 | 52 |
| Weighted Avg Shares Out Dil | 62 | 62 | 58 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$14 | -$9 | -$11 | -$9 |
| % Margin | – | – | – | – |